{"document_type": "article", "byline": {"person": [{"role": "reported", "firstname": "Robert", "organization": "", "rank": 1, "lastname": "CYRAN"}], "original": "By ROBERT CYRAN"}, "news_desk": "Business", "slideshow_credits": null, "abstract": null, "multimedia": [], "headline": {"kicker": "Breakingviews", "content_kicker": "Breakingviews", "main": "Strategy of Alere Board Paid Off With Buyout by Abbott"}, "print_page": null, "keywords": [{"value": "Mergers, Acquisitions and Divestitures", "is_major": "N", "rank": "1", "name": "subject"}, {"value": "Abbott Laboratories", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "Alere Inc", "is_major": "N", "rank": "3", "name": "organizations"}], "snippet": "The diligence of the board of Alere, a diagnostic tester, brought a chunky 51 percent premium in the $5.8 billion sale to Abbott, announced on Monday.", "source": "The New York Times", "lead_paragraph": "The diligence of the board of Alere, a diagnostic tester, brought a chunky 51 percent premium in the $5.8 billion sale to Abbott, announced on Monday.", "word_count": "345", "pub_date": "2016-02-02T00:00:00Z", "subsection_name": "DealBook", "blog": [], "type_of_material": "News", "section_name": "Business Day", "web_url": "http://www.nytimes.com/2016/02/02/business/dealbook/strategy-of-alere-board-paid-off-with-buyout-by-abbott.html", "_id": "56af9db138f0d8491255922f"}